Rating History for Hillstream BioPharma (HILS) by Dawson James

More Stocks Rated by Dawson James | Latest Ratings for HILS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/17/2023 Jason Kolbert Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.38
(0.23)		 -39.47% Details